NCT06440148 Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis
| NCT ID | NCT06440148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Lublin |
| Condition | Mastocytosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2019-09-01 |
| Primary Completion | 2024-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2019-09-01 with a primary completion date of 2024-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mastocytosis is very rare and highly heterogeneous group of disorders, characterized by the accumulation of clonal mast cells which can infiltrate several organs and tissues. Bones are the most frequent localization of systemic mastocytosis. The aim of our research was to explain the potential role of sclerostin in the pathogenesis of bone disease in mastocytosis.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * Mastocytosis defined according to WHO criteria * Known KIT mutation status Exclusion Criteria: * History of organ transplant * Inability to give informed consent * Pregnancy, Breastfeeding * Vulnerable Patient, defined as: patient with another uncontrolled severe disease; patient under juridical protection
Contact & Investigator
Aneta A Szudy-Szczyrek, MD., PhD.
PRINCIPAL INVESTIGATOR
Medical University of Lublin
Frequently Asked Questions
Who can join the NCT06440148 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mastocytosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06440148 currently recruiting?
Yes, NCT06440148 is actively recruiting participants. Contact the research team at aneta.szudy-szczyrek@umlub.pl for enrollment information.
Where is the NCT06440148 trial being conducted?
This trial is being conducted at Lublin, Poland.
Who is sponsoring the NCT06440148 clinical trial?
NCT06440148 is sponsored by Medical University of Lublin. The principal investigator is Aneta A Szudy-Szczyrek, MD., PhD. at Medical University of Lublin. The trial plans to enroll 50 participants.